Mechanism of Fluconazole Resistance in Candida krusei

National Committee for Clinical Laboratory Standards

Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736

The Carbon Monoxide-binding Pigment of Liver Microsomes

Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781

Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465

Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation

Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351

The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans

White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292

Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility

Geber, A., Hitchcock, C. A., Swartz, J. E., Pullen, F. S., Marsden, K. E., Kwon-Chung, K. J., & Bennett, J. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2708 · Cited by 203

The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity

Lamb, D. C., Kelly, D. E., Schunck, W., Shyadehi, A. Z., Akhtar, M., Lowe, D. J., Baldwin, B. C., & Kelly, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5682 · Cited by 192

Interaction of azole antifungal antibiotics with cytochrome P -450-dependent 14α-sterol demethylase purified from Candida albicans

Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1990) · Biochemical Journal · doi:10.1042/bj2660475 · Cited by 189

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

Parkinson, T., Falconer, D. J., & Hitchcock, C. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1696 · Cited by 129

Resistance of Candida albicans to azole antifungal agents

Hitchcock, C. A. (1993) · Biochemical Society Transactions · doi:10.1042/bst0211039 · Cited by 118

Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment

Burgener-Kairuz, P., Zuber, J. P., Jaunin, P., Buchman, T. G., Billé, J., & Rossier, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1902-1907.1994 · Cited by 114

Invasive Infections Due to Candida krusei: Report of Ten Cases of Fungemia that Include Three Cases of Endophthalmitis

McQuillen, D. P., Zingman, B. S., Meunier, F., & Levitz, S. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.472 · Cited by 86

Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei

Fisher, M. A., Shen, S. H., Haddad, J., & Tarry, W. F. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1443 · Cited by 81

Candida krusei Fungemia

Goldman, M., Pottage, J. C., & Weaver, D. C. (1993) · Medicine · doi:10.1097/00005792-199305000-00002 · Cited by 78

Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance

Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2443 · Cited by 58

Dimorphism-associated Variations in the Lipid Composition of Candida albicans

Ghannoum, M. A., Janini, G. M., Khamis, L., & Radwan, S. S. (1986) · Microbiology · doi:10.1099/00221287-132-8-2367 · Cited by 56

Origin of differences in susceptibility of Candida krusei to azole antifungal agents

Marichal, P., Gorrens, J., Coene, M. C., Jeune, L. L., & BOSSCHE, H. V. (1995) · Mycoses · doi:10.1111/j.1439-0507.1995.tb00032.x · Cited by 51

Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Gottingen, Germany

Zepelin, M. B., Eiffert, H., Kann, M., & Rüchel, R. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00759.x · Cited by 48

Variation in lipid and sterol contents inCandida albicanswhite and opaque phenotypes

Ghannoum, M. A., Swairjo, I., & Soll, D. R. (1990) · Medical Mycology · doi:10.1080/02681219080000151 · Cited by 43

Purification and properties of cytochrome P-450-dependent 14 α-sterol demethylase from Candida albicans

Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1989) · Biochemical Journal · doi:10.1042/bj2630573 · Cited by 37

Sterols of the plant pathogenic fungi Botrytis cinerea and Pyrenophora teres

Loeffler, R. S. T., & Hayes, A. L. (1990) · Phytochemistry · doi:10.1016/0031-9422(90)85250-j · Cited by 36

Effects of Sterol Biosynthesis Inhibitor Fungicides on Growth and Sterol Composition of Ustilago maydis, Botrytis cinerea and Pyrenophora teres

Loeffler, R. S. T., & Hayes, A. L. (1992) · Pesticide Science · doi:10.1002/ps.2780360103 · Cited by 34

Convenient procedure for the isolation of highly enriched, cytochrome P-450-containing microsomal fraction from Candida tropicalis

Käppeli, O., Sauer, M., & Fiechter, A. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90126-9 · Cited by 33

Inhibition and interaction of cytochrome P450 ofCandida kruseiwith azole antifungal drugs

Venkateswarlu, K., Denning, D. W., & Kelly, S. (1997) · Medical Mycology · doi:10.1080/02681219780000821 · Cited by 31

Cytochrome P-450-dependent 14 α-demethylation of lanosterol in Candida albicans

Hitchcock, C. A., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1989) · Biochemical Journal · doi:10.1042/bj2600549 · Cited by 30

Reference high-efficiency nonpolar packed columns for the gas—liquid chromatography of nanogram amounts of steroids part I. Retention time data

Vandenheuvel, F. A., & Court, A. S. (1968) · Journal of Chromatography A · doi:10.1016/0021-9673(68)85073-3 · Cited by 30

Ketoconazole-mediated growth inhibition in Botrytis cinerea and Saccharomyces cerevisiae

Quail, M. A., Arnold, A. C., Moore, D. J., Goosey, M. W., & Kelley, S. L. (1993) · Phytochemistry · doi:10.1016/s0031-9422(00)94980-x · Cited by 30

Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays

Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1382 · Cited by 26

In vitro Susceptibility of Yeast Isolates from the Blood to Fluconazole and Amphotericin B

Dermoumi, H. L. (2009) · Chemotherapy · doi:10.1159/000238950 · Cited by 25

Growth of Candida albicans in the presence of hydrocarbons: a correlation between sterol concentration and hydrocarbon uptake

Sorkhoh, N. A., Ghannoum, M. A., Ibrahim, A. S., Stretton, R. J., & Radwan, S. S. (1991) · Applied Microbiology and Biotechnology · doi:10.1007/bf00180579 · Cited by 16

Reference high-efficiency nonpolar packed columns for the gas—liquid chromatography of nanogram amounts of steroids

Vandenheuvel, F. A., & Court, A. S. (1969) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)97970-1 · Cited by 14

The distinction of different types of cytochromes P-450 from the yeasts Candida tropicalis and Saccharomyces uvarum

Sanglard, D., Käppeli, O., & Fiechter, A. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90075-5 · Cited by 14

Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance

Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,811

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900

Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond

Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801

Nosocomial fungal infections: epidemiology, diagnosis, and treatment

Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619

Inhibition and interaction of cytochrome P450 ofCandida kruseiwith azole antifungal drugs

Venkateswarlu, K., Denning, D. W., & Kelly, S. (1997) · Medical Mycology · doi:10.1080/02681219780000821 · Cited by 31

Fluconazole resistance mechanisms inCandida krusei: The contribution of efflux-pumps

Guinea, J., Sánchez-Somolinos, M., Cuevas, Ó., Peláez, T., & Bouza, E. (2006) · Medical Mycology · doi:10.1080/13693780600561544 · Cited by 58

Short Communication Fluconazole resistance mechanisms in Candida krusei: The contribution of efflux-pumps

Guinea, J., Cuevas, O., & Bouza, E. (2016)

Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance

Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2443 · Cited by 58

Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei

Fukuoka, T., Johnston, D. A., Winslow, C. A., de Groot, M. J., Burt, C., Hitchcock, C. A., & Filler, S. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1213-1219.2003 · Cited by 97